VTRS: third_quarter 2026 lobbying report

{"url":"https://lda.gov/api/v1/filings/9dc590da-584c-480c-9440-4484b7cd3475/","filing_uuid":"9dc590da-584c-480c-9440-4484b7cd3475","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/9dc590da-584c-480c-9440-4484b7cd3475/print/","filing_document_content_type":"text/html","income":"70000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Cristina Antelo","dt_posted":"2026-10-19T16:20:57-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"309 Pennsylvania Ave SE","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20003","registrant":{"id":401104769,"url":"https://lda.gov/api/v1/registrants/401104769/","house_registrant_id":null,"name":"FEROX STRATEGIES","description":"Government relations.","address_1":"309 Pennsylvania Avenue SE","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20003","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"CRISTINA ANTELO","contact_telephone":"+1 202-320-8236","dt_updated":"2026-07-30T18:00:40.247718-04:00"},"client":{"id":202668,"url":"https://lda.gov/api/v1/clients/202668/","client_id":24,"name":"VIATRIS INC","general_description":"Pharmaceutical company","client_government_entity":false,"client_self_select":null,"state":"PA","state_display":"Pennsylvania","country":"US","country_display":"United States of America","ppb_state":"PA","ppb_state_display":"Pennsylvania","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2018-03-01"},"lobbying_activities":[{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Policy and oversight related to the generic pharmaceutical industry. Issues related to drug pricing. Issues related to FDA generic drug approval process. General issues related to Agriculture Appropriations and National Defense Authorization Act (S. 1071).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":67961,"prefix":null,"prefix_display":null,"first_name":"CRISTINA","nickname":null,"middle_name":null,"last_name":"ANTELO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71787,"prefix":null,"prefix_display":null,"first_name":"MARK","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146075,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"TAGGART","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":93773,"prefix":null,"prefix_display":null,"first_name":"DEBRA","nickname":null,"middle_name":null,"last_name":"DIXON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152876,"prefix":"mr","prefix_display":"MR.","first_name":"ZACHARY","nickname":null,"middle_name":"BENJAMIN","last_name":"FRIEND","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Trade issues related to generic medicines.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":71787,"prefix":null,"prefix_display":null,"first_name":"MARK","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":22,"name":"U.S. Trade Representative (USTR)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}